Sanofi-Aventis to invest in R&D in Spain
Business Investments
01 Apr 2012
France-based pharmaceutical company Sanofi-aventis plans to invest $1.3 million in research and development (R&D) projects of Barcelona's international biomedical research institute CRG.
The projects include cell reprogramming, the application of synthetic biology technology to treat lung diseases, the influence of genes as factor for some diseases and tuberculosis treatment, the director of CRG, Luis Serrano, said.
Source: IPA WORLD, 8/3/2012
Related News and Success stories.
-
19 Sep 2025
See more APM Terminals invests €156 million in Barcelona to boost Mediterranean logistics hubAPM Terminals invests €156 million in Barcelona to boost Mediterranean logistics hub
-
18 Sep 2025
See more DHL Express inaugurates new €80M international hub in BarcelonaDHL Express inaugurates new €80M international hub in Barcelona
-
17 Sep 2025
See more Japanese multinational AGC opens new plant in Catalonia with over €100M investmentJapanese multinational AGC opens new plant in Catalonia with over €100M investment
-
15 Sep 2025
See more Trace ID opens new 2,000 m2 chip welding plant in Barcelona, a European firstTrace ID opens new 2,000 m2 chip welding plant in Barcelona, a European first
